{"text": ["European", "agency", "highlights", "blood", "clot", "risks", "from", "Pfizer's", "arthritis", "drug"], "created_at": "2019-10-31 15:48:39"}
{"text": ["Exelixis", "(EXEL)", "Q3", "Earnings", "Beat", "on", "Strong", "Cabometyx", "Sales"], "created_at": "2019-10-31 15:45:03"}
{"text": ["Bristol-Myers'", "(BMY)", "Q3", "Earnings", "&", "Revenues", "Beat", "Estimates"], "created_at": "2019-10-31 15:37:03"}
{"text": ["Glaxo", "(GSK)", "Beats", "Q3", "Earnings", "Estimates,", "Raises", "'19", "EPS", "View"], "created_at": "2019-10-31 15:27:03"}
{"text": ["A", "Closer", "Look", "At", "Pfizer", "Inc.'s", "(NYSE:PFE)", "Impressive", "ROE"], "created_at": "2019-10-31 14:57:17"}
{"text": ["Small", "biotech", "Pinteon", "eyes", "large", "goal:", "a", "treatment", "for", "Alzheimer's"], "created_at": "2019-10-31 09:00:00"}
